Test kits.

Ended Awarded

Contract number
HT009022FG0320002
Awardee
Awarding agency
Obligated
$14,182

Award facts

Contract value 100% obligated
$14,181.97 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Competed under SAP · 3 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Castleton, IN 46256, USA

Award details come from SAM.gov/FPDS.

About this award

Roche Diagnostics Corporation was awarded a firm fixed price blanket purchase agreement (BPA) call contract by the Defense Health Agency on March 1, 2022. The contract is valued at $14,181.97 to provide test kits with no set-aside designation. Performance will take place in Castleton, Indiana through the contract's completion date of September 30, 2022. As the sole awardee, Roche Diagnostics Corporation will deliver the requested test kits to support the Defense Health Agency's medical testing programs.

Quick answers

Who was awarded contract HT009022FG0320002?

HT009022FG0320002 was awarded to Roche Diagnostics Corporation by Defense Health Agency (Department of Defense) on March 1, 2022.

How much is contract HT009022FG0320002 worth?

The government has obligated $14,182 on HT009022FG0320002.

Is contract HT009022FG0320002 an order under another contract?

Yes. HT009022FG0320002 is a BPA call under W91YTZ21A0009, a blanket purchase agreement.

Was contract HT009022FG0320002 competed?

The extent of competition for HT009022FG0320002 was competed under sap. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award